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Rationale:Past researchdemonstrates apossible associationbetween
herbicide exposure and respiratory health. Biologic plausibility and
inhalation as a mode of exposure further support the contention that
herbicides may act as adverse contributors to respiratory status,
especially in military personnel who were responsible for chemical
maintenance and distribution during the VietnamWar.
Objectives: This study examines the association between chronic
obstructive pulmonary disease and herbicide exposure among
Vietnam-era U.S. Army Chemical Corps veterans.
Methods: A 2013 three-phase health study was conducted that
included a survey (mail or telephone), in-home physical
examinations, and medical record reviews/abstractions.
Living, eligible veterans (n = 4,027) were identiﬁed using an existing
cohort of men (n = 5,609) who either served in Vietnam (n = 2,872)
or never served in Southeast Asia (n = 2,737). The health survey
collected self-reported data on physician-diagnosed pulmonary
conditions (chronic obstructive pulmonary disease, emphysema, and
chronic bronchitis), service-related herbicide spraying history,
cigarette smoking status, alcohol use, and demographics. Data from
service personnel ﬁles conﬁrmed chemical operations involvement
and service status, whereas serum samples analyzed for 2,3,7,8-
tetrachlorodibenzo-p-dioxin supported self-reported herbicide
exposure. National Institute for Occupational Safety and Health
quality-assured spirometry was performed during the physical
examinations on a subset of survey respondents (n = 468 of 733
selected for participation and who provided consent) to determine
mainly spirometric obstructive respiratory disease (forced
expiratory volume in 1 second [FEV1]/forced vital capacity
[FVC], lower limit of normal [LLN], FVC> LLN, and FEV1,
LLN; and FEV1/FVC, LLN and FEV1> LLN). Associations
between chronic obstructive pulmonary disease and veteran
characteristics were examined (n = 403) usingmultivariablemodels.
Results: Reporting here speciﬁcally on spirometrically diagnosed
disease, prevalence of obstructive disease was 8.4%. No signiﬁcant
differences in mean values of FEV1/FVC or mean percentage of
predicted for FEV1 and FVC between herbicide sprayers and
nonsprayerswere found. The odds of spirometric obstructive disease
among sprayers were 0.65 times the odds among nonsprayers
(adjusted odds ratio, 0.65; 95% conﬁdence interval, 0.28–1.47),
although elevated odds for spirometric restrictive disease were
observed for sprayers versus nonsprayers (adjusted odds ratio, 1.61;
95%conﬁdence interval, 0.85–3.06). Race/ethnicity, anthropometric
measures, and cigarette smoking status accounted for differences
among veterans’ respiratory patterns.
Conclusions: No signiﬁcant association between herbicide
exposure and spirometry-determined chronic obstructive
pulmonary disease was found. Greater focus is required on
conﬁrming diagnoses of respiratory disease through spirometry in
epidemiological research.
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Rationale: Household air pollution (HAP) and human
immunodeﬁciency virus (HIV) are associatedwith increased risk for
chronic obstructive pulmonary disease. Both HAP and HIV are
widespread in Sub-Saharan Africa, including Malawi, where HIV
has 10.6% prevalence in patients 15–49 years old.
S132 AnnalsATS Volume 15 Supplement 2| April 2018
ABSTRACTS
Objectives:We hypothesized that HIV infection (HIV1) and
habitual exposure to HAP (HAP1) synergize to cause systemic
inﬂammation and vascular injury, which may herald early onset of
chronic respiratory diseases.
Methods: In this pilot study, 50 subjects from Malawi with
known HIV status were administered surveys recording
demographics, HAP exposure, and respiratory symptoms/
diagnoses. Peripheral blood was collected, and Meso Scale
Discovery V-Plex assay was used to measure the levels of 41
serum markers.
Results:Almost all subjects (96%) reportedHAP1, 30 were HIV1,
20 were HIV2, with a mean age of 22 years in both groups. More
females (73%) were HIV1, whereas 65% of those who were HIV2
were males. The vast majority were never-smokers (70% of HIV2
and 83% of HIV1 subjects, respectively). Forty-six percent
of all subjects (57% of HIV1HAP1 and 33% of HIV2HAP1)
reported respiratory diagnoses and/or respiratory symptoms,
with breathlessness and cough being most common. Although
HIV1HAP1 individuals had a trend to increased proinﬂammatory
cytokines and vascular injurymarkers, anddecreases inproangiogenic
factors compared with HIV2HAP1, only the decrease in serum
interleukin-16 (by 44%) was statistically signiﬁcant (P = 0.03). Also,
compared with other subjects, serum interleukin-2 levels were
signiﬁcantly decreased (by 31%; P = 0.02) in HIV1 subjects with
persistent respiratory symptoms.
Conclusions: This study suggests a high prevalence of respiratory
symptoms in HIV1 individuals exposed to HAP. The signiﬁcant
decrease in interleukin-2 and interleukin-16, cytokines associatedwith
HIV clearance, may contribute to viral persistence, and because their
low levels were found to correlate with chronic obstructive pulmonary
disease severity, they may serve as biomarkers for risk of chronic
obstructive pulmonary disease in this vulnerable population.
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Chronic beryllium disease is a granulomatous lung disease,
characterized by the accumulation of macrophages and
beryllium-speciﬁc CD41 T-cells that proliferate and produce
T-helper cell type 1 cytokines. Previous studies indicate that
beryllium-mediated oxidative stress enhances cytokine response in
chronic beryllium disease CD41 T-cells. 5-Aminosalicylic acid
(5-ASA) is currently used to treat inﬂammatory bowel disease
and has both antioxidant and antiinﬂammatory actions. We
hypothesized that 5-ASA therapy may be a beneﬁcial therapy in
chronic beryllium disease. An investigator-initiated, randomized,
double-blind, placebo-controlled 5-ASA trial was undertaken.
Patients with chronic beryllium disease were randomized 3:1
to receive 5-ASA (500-mg capsules) four times daily (n = 13)
or placebo capsules (n = 5), for 6 weeks. Primary study
endpoints included changes in beryllium lymphocyte proliferation
test responses in peripheral blood mononuclear cells and
bronchoalveolar lavage cells. Secondary endpoints included
changes in bronchoalveolar lavage ﬂuid cells, serum, and
peripheral blood mononuclear cell glutathione levels,
bronchoalveolar lavage cell–stimulated tumor necrosis factor-a
levels, lung function, and quality of life as measured by the Short
Form 36 questionnaire. 5-ASA decreased bronchoalveolar lavage
cell beryllium lymphocyte proliferation test responses by 20%
within the 5-ASA treatment group (P = 0.06), although this was not
seen for blood beryllium lymphocyte proliferation test responses. No
signiﬁcant changes were observed in serum, peripheral blood
mononuclear cells, bronchoalveolar lavage ﬂuid, or bronchoalveolar
lavage cell glutathione levels in either the 5-ASA or placebo treatment
group. 5-ASA treatment decreased ex vivo beryllium-stimulated
bronchoalveolar lavage cell tumor necrosis factor-a levels within the
5-ASA group (P = 0.06) and when compared with placebo (P = 0.04).
Signiﬁcant improvements were noted in quality of life measurements
with 5-ASA treatment. The ability of 5-ASA to decrease
bronchoalveolar lavage cell beryllium lymphocyte proliferation test
responses and diminish beryllium-stimulated bronchoalveolar lavage
cell tumornecrosis factor-a levels suggests that 5-ASAmay impact the
beryllium-speciﬁc immune response in chronic beryllium disease.
Clinical trial registered with www.clinicaltrials.gov
(NCT01088243).
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